21.482 articles found

Riluzole and levodopa combinations for treating parkinson's disease

Check source for author details

· 1999-04-22

COMBINATION OF LEVODOPA AND RILUZOLE FOR TREATING COMBINATION OF LEVODOPA AND RILUZOLE FOR TREATING PARKINSON DISEASE PARKINSON DISEASE

Check source for author details

· 1999-04-22

Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study.

Pinter MM, Pogarell O, Oertel WH.

J Neurol Neurosurg Psychiatry · 1999-04-01

DOI: 10.1136/jnnp.66.4.436PMID: 10201413

Affective symptoms in multiple system atrophy and Parkinson's disease: response to levodopa therapy.

Fetoni V, Soliveri P, Monza D, Testa D, Girotti F.

J Neurol Neurosurg Psychiatry · 1999-04-01

DOI: 10.1136/jnnp.66.4.541PMID: 10201434

Subthalamic nucleus stimulation improves directly levodopa induced dyskinesias in Parkinson's disease.

Figueiras-Méndez R, Marín-Zarza F, Antonio Molina J, Jiménez-Jiménez FJ, Ortí-Pareja M, Magariños C, López-Pino MA, Martínez V.

J Neurol Neurosurg Psychiatry · 1999-04-01

DOI: 10.1136/jnnp.66.4.549PMID: 10201440

Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder.

Robinson DG, Woerner MG, Alvir JM, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Bilder R, Goldman R, Lieberman JA.

Am J Psychiatry · 1999-04-01

DOI: 10.1176/ajp.156.4.544PMID: 10200732

Constrictive pericarditis and pleuropulmonary disease linked to ergot dopamine agonist therapy (cabergoline) for Parkinson's disease.

Ling LH, Ahlskog JE, Munger TM, Limper AH, Oh JK.

Mayo Clin Proc · 1999-04-01

DOI: 10.4065/74.4.371PMID: 10221467

Therapeutic potential of nerve growth factors in Parkinson's disease.

Collier TJ, Sortwell CE.

Drugs Aging · 1999-04-01

DOI: 10.2165/00002512-199914040-00003PMID: 10319241

[Drug therapy in Parkinson's disease].

Jansen EN.

Ned Tijdschr Geneeskd · 1999-04-01

PMID: 10347646

Therapy of behavioral disorders in Parkinson's disease.

Valldeoriola F, Molinuevo J.

Biomed Pharmacother · 1999-04-01

DOI: 10.1016/s0753-3322(99)80081-xPMID: 10349504

[Motor complications of treatment with levodopa in Parkinson's disease].

García-Escrig M, Bermejo-Pareja F.

Rev Neurol · 1999-04-01

DOI: 10.33588/rn.2808.98214PMID: 10363326

[Entacapone: is it useful as complimentary treatment with levodopa?].

Burguera JA, Grandas F, Horga de la Parte JF, Luquin R, Martí F, Matías-Guiu J, Obeso JA, Kulisevsky J.

Rev Neurol · 1999-04-01

DOI: 10.33588/rn.2808.99183PMID: 10363328